ArticleEvidence-based complementary and alternative medicine : eCAM2022
Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 33 citations in OpenAlex.
- Pharmacological Assessment ofFood science & nutrition · 2026Article
- Discovery of Inhibitory Active Ingredients for α-Amylase and α-Glucosidase from Raspberry (Foods (Basel, Switzerland) · 2026Article
- Phytochemical Profile and Bioactive Potential ofCurrent issues in molecular biology · 2026Article
- GB5, a synergistic phytotherapy for type 2 diabetes mellitus management: an integrated polyherbal approach from phytochemical profiling to network pharmacology.BMC complementary medicine and therapies · 2025Article
- The Potential Therapeutic Use of Agarwood for Diabetes: A Scoping Review.Pharmaceuticals (Basel, Switzerland) · 2024Article
- Pro-Apoptotic Activity ofPharmaceuticals (Basel, Switzerland) · 2023Article
- Review
- Quality, Safety and Biological Studies onPharmaceuticals (Basel, Switzerland) · 2023Article
- To Investigate the Potential Mechanism of Huanglian Jiangtang Formula Lowering Blood Sugar in View of Network Pharmacology and Molecular Docking Technology.Evidence-based complementary and alternative medicine : eCAM · 2023Article
- Article
- Xuanhuang Runtong Tablets Relieve Slow Transit Constipation in Mice by Regulating TLR5/IL-17A Signaling Mediated by Gut Microbes.Evidence-based complementary and alternative medicine : eCAM · 2023Article
- TheEvidence-based complementary and alternative medicine : eCAM · 2023Article
- Integrated Network Pharmacology and Proteomic Analyses of Targets and Mechanisms of Jianpi Tianjing Decoction in Treating Vascular Dementia.Evidence-based complementary and alternative medicine : eCAM · 2023Article
- Herbal Tea Essences (HTE) Ameliorate HFD-Induced Obesity.Evidence-based complementary and alternative medicine : eCAM · 2022Article
- Investigating Polyphenol Nanoformulations for Therapeutic Targets against Diabetes Mellitus.Evidence-based complementary and alternative medicine : eCAM · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For the treatment and maintenance of postprandial blood glucose increases (i.e., diabetes mellitus), alpha (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.